Introduction
The greater chance of survival for those who stop smoking cigarettes after a coronary attack is well documented,1-10 but only one report (with negative findings) mentions explicitly the relation between stopping smoking cigarettes and subsequent angina pectoris.8 This paper examines this question in a long term follow up study of 408 men who smoked and survived a first attack of unstable angina or myocardial infarction and were entered into the St Vincent's Hospital heart study.
Patients and methods
Between 1 January 1965 and 31 December 1975, 555 consecutive men aged under 60 who survived a first attack of unstable angina or myocardial infarction by at least 28 days were admitted into a long term follow up study. Diagnostic criteria for entry to the study have been previously published.' This report concentrates on the 408 (73-4%) of those patients who were smoking one or more cigarettes daily in the three months before their attack. Of these, 81 (19-9%) had a diagnosis of unstable angina.
A uniform programme of rehabilitation and secondary prevention included advice in hospital and at follow up against smoking. Routine drugs such as anticoagulants or f blockers were not used. Follow up data were recorded annually at a special clinic, and 384 of the 408 patients who smoked before the study began were alive at their first ("one year") examination (mean time to examination was 13-8 months). Subsequent long term follow up of these 384 in the smokers who had stopped and continued, respectively. The figure shows these curves. Deaths were treated as withdrawals from the life table, so that essentially this approach calculated the proportion expected to have experienced angina if there had been no deaths. The figure shows clearly that there was a catch up effect and that after almost six years (seven years from the first attack) angina in the smokers who had continued and stopped was the same. This explains the observed lack of influence of stopping smoking on long term angina. An analysis stratified by the anginal state before infarction showed a similar catch up effect.
Discussion
Two published reports suggest a beneficial effect of stopping smoking on angina in patients with established coronary heart disease. The data from the coronary drug project on 2789 survivors of myocardial infarction are difficult to interpret, however, because of the method used to categorise smoking state.1' The results of a recent crossover trial on 10 patients with chronic stable angina are only indicative because of the small numbers considered." The only study that examined the question explicitly found no effect in 1023 survivors of myocardial infarction. 8 This study was carried out to determine the short term and long term effects on subsequent angina of stopping smoking in survivors of a coronary attack who had smoked when the study began. Non-smokers were not included. Long term angina in this paper was based on a cumulative score that was independent of the number of survivors in the groups under comparison. It thus neutralised a potential masking effect caused by the known relation between stopping smoking and mortality-stopped Years from first follow up examination Proportion of patients (%0) who experienced any angina after infarction subsequent to first annual examination in smokers who stopped (-) and continued ( -) (corrected for mortality).
smokers might have reported more angina simply because they lived longer and so had more time to develop it. The presence of angina before infarction was strongly related to the prevalence of angina one year after the first attack and to long term angina over the subsequent 17 years. Stopping smoking was independently associated with a 40% reduction in the prevalence of angina at one year but was not related to the score for long term angina. This was explained, however, by an analysis of the proportion of patients who experienced any angina after infarction over time. The results showed that roughly six years after stopping smoking the proportions who had experienced any angina in smokers who had stopped and continued were the same.
The known relation between habitual smoking of cigarettes and increased concentrations of carboxyhaemoglobin, and the observation that raised carboxyhaemoglobin concentrations will aggravate angina that is induced by exercise,'6 lend credence to our findings. We conclude that, in addition to reducing long term mortality and further non-fatal coronary events, a patient who stops smoking after infarction delays the onset of angina pectoris, though the effect is not maintained in the long term.
We thank all the staff, past ) had a serum creatine kinase activity of over 3000 U/i (mid 95% reference interval 50-230 U/1), which was thought to have been caused by hypocalcaemic convulsions. After treatment with intravenous calcium the patient had no further convulsions, though serum creatine kinase activity remained high, which was surprising as serum creatine kinase has a half life of about 34 hours. When treated with calcitriol the patient's serum calcium concentration gradually returned to normal as did serum creatine kinase activity. This observation led us to study serum creatine kinase activity in other patients. Ten patients with severe hypocalcaemia, eight with hyperphosphataemia but no appreciable hypocalcaemia, and nine with various severe illnesses but normal serum calcium and phosphate concentrations (controls) were studied. No patients had clinically obvious cardiac or skeletal muscle disease.
For each patient serum calcium concentrations and serum creatine kinase activities were determined at least twice on different days in different blood specimens, which were separated promptly and analysed within four hours of collection. Creatine kinase activity and magnesium concentrations were measured by Dupont ACA methods; all other biochemical tests were performed by standard SMAC 1 methods. We corrected serum calcium concentrations using the following formula: corrected serum calcium concentration (mmol/l)= serum calcium concentration (mmol/l) + ((41-serum albumin concentration (g/l)) X 0-019). The mean normal serum albumin concentration for our population and method was 41 g/l. The *Electophoretic studies showed increased creatine kinase activity to be exclusively due to the MM (skeletal muscle) isoenzyme.
Conversion: SI to traditional units-Serum calcium: 1 mmol/Il 4 mg/100 ml. Serum creatinine: 1 gmol/l z 0 011 mg/100 ml. Serum magnesium: 1 mmol/I l 2 4 mg/100 ml.
Serum phosphate: 1 mmol/13-1 mg/100 ml.
